Target intelligence / Profile preview

Proteasome assembly chaperone 1 (PSMG1)

Target
PSMG1
Molecular classification
Protein chaperone, Assembly factor, Other
01

Overview

Proteasome assembly chaperone 1 (PSMG1) is an evolutionarily conserved, ubiquitously expressed protein chaperone responsible for promoting the assembly of the α-ring of the 20S core particle (CP) in the eukaryotic proteasome[2][1][3]. PSMG1 functions as part of a heterodimeric complex with PSMG2 (PAC2) to enable proper biogenesis and stability of the proteasome, preventing the formation of non-productive α-ring dimers and ensuring incorporation of subunits during proteasome maturation[3][2][1]. Disruption of PSMG1 leads to proteasome dysfunction and, in animal models, to embryonic lethality, highlighting its fundamental importance in cellular homeostasis[2]. The gene is located on human chromosome 21 and may also be known by aliases relating to Down syndrome due to its chromosomal localization[5][1]. Abnormalities or altered expression of PSMG1 have been linked to processes and diseases including cancer progression, protein quality control disorders, and inflammation[4][1]. Currently, there are no approved drugs targeting PSMG1 directly, and it is not known to interact with small molecule drugs or act as a classical therapeutic target receptor or enzyme[4][1].

Other names
Proteasome assembly chaperone 1PSMG1PAC1DSCR2C21LRPPba1Chromosome 21 leucine-rich proteinDown syndrome critical region protein 2LRPC21proteasome chaperone homolog 1proteasome (prosome, macropain) assembly chaperone 1
02

Biological functions

Protein complex assemblyChaperone-mediated protein foldingProteasome assembly and stabilizationRegulation of proteostasis
03

Disease associations

CancerNeurodevelopmental disorders (e.g., Down syndrome due to chromosomal localization)InflammationCellular stress response
04

Safety considerations

No specific, clinically documented safety concerns; loss of function in animal models causes embryonic lethality, indicating essential cellular roles[2]
05

Biomarkers

Candidate biomarker in certain cancers (e.g., lung adenocarcinoma)[4]

Beyond the preview

Go deeper on Proteasome assembly chaperone 1 (PSMG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteasome assembly chaperone 1 (PSMG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call